Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathuram Santosham

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Vaccine|September 1, 2021
Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studiesAbdullah H Baqui, Alain K Koffi, Eric D McCollum, et al.
Global Health Research and Policy|July 4, 2020
The need for COVID-19 research in low- and middle-income countriesMadhu Gupta, Brian Wahl, Binita Adhikari, et al.
Vaccine|September 3, 2020
Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control studyEric D McCollum, Salahuddin Ahmed, Arun D Roy, et al.
Vaccine|April 30, 2023
Considerations for unblinding individual study participants during vaccine trialsNeal Halsey, Stephen Evans, Mathuram Santosham, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
Plos One|February 14, 2020
Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in BangladeshAbdullah H Baqui, Eric D McCollum, Arif Mahmud, et al.
Journal of Global Health|December 16, 2021
Validation of community health worker identification of maternal puerperal sepsis using a clinical diagnostic algorithm in Bangladesh and PakistanAmnesty E LeFevre, Fatima Mir, Dipak K Mitra, et al.
Plos Medicine|June 3, 2024
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedulesAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
The Lancet. Global Health|April 6, 2015
Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trialAbdullah H Baqui, Samir K Saha, A S M Nawshad Uddin Ahmed, et al.
Gates Open Research|July 10, 2018
Pneumococcal Conjugate Vaccine impact assessment in BangladeshAbdullah H Baqui, Eric D McCollum, Samir K Saha, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Vaccine|September 1, 2021
Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studiesAbdullah H Baqui, Alain K Koffi, Eric D McCollum, et al.
Global Health Research and Policy|July 4, 2020
The need for COVID-19 research in low- and middle-income countriesMadhu Gupta, Brian Wahl, Binita Adhikari, et al.
Vaccine|September 3, 2020
Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control studyEric D McCollum, Salahuddin Ahmed, Arun D Roy, et al.
Vaccine|April 30, 2023
Considerations for unblinding individual study participants during vaccine trialsNeal Halsey, Stephen Evans, Mathuram Santosham, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
Plos One|February 14, 2020
Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in BangladeshAbdullah H Baqui, Eric D McCollum, Arif Mahmud, et al.
Journal of Global Health|December 16, 2021
Validation of community health worker identification of maternal puerperal sepsis using a clinical diagnostic algorithm in Bangladesh and PakistanAmnesty E LeFevre, Fatima Mir, Dipak K Mitra, et al.
Plos Medicine|June 3, 2024
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedulesAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
The Lancet. Global Health|April 6, 2015
Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trialAbdullah H Baqui, Samir K Saha, A S M Nawshad Uddin Ahmed, et al.
Gates Open Research|July 10, 2018
Pneumococcal Conjugate Vaccine impact assessment in BangladeshAbdullah H Baqui, Eric D McCollum, Samir K Saha, et al.
Pageof 21